Before Invest
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON

JNJ
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 28, 2026
Financial Statements Ratios
Export XLSX
Unlock 40 quarters
Statement
Period
Annual Quarterly
Order
Format
% Change
Rows
USD ($)
$ in Millions, shares in Millions		Jun 28, 2026Mar 29, 2026Sep 28, 2025Jun 29, 2025Mar 30, 2025Sep 29, 2024Jun 30, 2024Mar 31, 2024Oct 1, 2023Jul 2, 2023Apr 2, 2023Oct 2, 2022Jul 3, 2022Apr 3, 2022Oct 3, 2021Jul 4, 2021Apr 4, 2021Sep 27, 2020Jun 28, 2020Mar 29, 2020Sep 29, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jul 1, 2018Apr 1, 2018Oct 1, 2017Jul 2, 2017Apr 2, 2017Oct 2, 2016Jul 3, 2016Apr 3, 2016Sep 27, 2015Jun 28, 2015Mar 29, 2015Sep 28, 2014Jun 29, 2014Mar 30, 2014Sep 29, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012Jul 1, 2012Apr 1, 2012Oct 2, 2011Jul 3, 2011Apr 3, 2011Oct 3, 2010Jul 4, 2010Apr 4, 2010Sep 27, 2009Jun 28, 2009
Sales to customers (Note 9)
$ 25,310
$ 24,062
$ 23,993
$ 23,743
$ 21,893
$ 22,471
$ 22,447
$ 21,383
$ 21,351
$ 25,530
$ 24,746
$ 23,791
Sales to customers percent to sales
1
1
1
1
1
1
1
1
1
1
1
1
Cost of products sold
8,051
8,106
7,303
7,628
7,357
6,963
6,869
6,511
6,606
8,212
8,395
7,807
Cost of products sold percent to sales
0.32
0.34
0.3
0.32
0.34
0.31
0.31
0.3
0.31
0.32
0.34
0.33
Gross profit
17,259
15,956
16,690
16,115
14,536
15,508
15,578
14,872
14,745
17,318
16,351
15,984
Gross Profit Percent To Sales
0.68
0.66
0.7
0.68
0.66
0.69
0.69
0.7
0.69
0.68
0.66
0.67
Selling, marketing and administrative expenses
6,432
6,034
5,922
5,889
5,112
5,478
5,681
5,257
5,400
6,665
6,138
6,089
Selling marketing and administrative expenses percent to sales
0.25
0.25
0.25
0.25
0.23
0.24
0.25
0.25
0.25
0.26
0.25
0.26
Research and development expense
3,653
3,527
3,672
3,516
3,225
4,952
3,440
3,542
3,447
3,829
3,563
3,597
Research and development expense percent to sales
0.14
0.15
0.15
0.15
0.15
0.22
0.15
0.17
0.16
0.15
0.14
0.15
In-process research and development impairments
-
36
-
0
-
0
194
0
206
-
49
0
In-process research and development percent to sales
-
0
-
0
-
0
0.01
0
0.01
-
0
0
Interest income
219
229
227
260
332
292
395
364
374
369
235
150
Interest income percent to sales
(0.01)
(0.01)
(0.01)
(0.01)
(0.01)
(0.01)
(0.02)
(0.02)
(0.02)
(0.01)
(0.01)
(0.01)
Interest expense, net of portion capitalized
(281)
(272)
(245)
(308)
(204)
(193)
(270)
(155)
(192)
(346)
(215)
(51)
Interest expense, net of portion capitalized percent to sales
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0
Other (income) expense, net
(331)
(294)
478
(107)
7,321
(1,798)
(653)
(2,404)
(499)
60
(7,228)
(493)
Other (income) expense, net percent to sales
0.01
0.01
(0.02)
0.01
(0.33)
0.08
0.03
0.11
0.02
0
0.29
0.02
Restructuring (Note 12)
34
32
63
64
17
41
(13)
164
158
145
130
82
Restructuring charge percent to sales
0
0
0
0
0
0
0
0.01
0.01
0.01
0.01
0
Earnings before provision for taxes on income
6,747
5,990
7,493
6,491
13,631
3,338
5,748
3,714
5,217
6,762
(737)
5,822
Restructuring expense Percent to Sales
-
-
-
-
-
-
-
-
-
-
-
-
Earnings before provision for taxes on income percent to sales
0.27
0.25
0.31
0.27
0.62
0.15
0.26
0.17
0.24
0.27
(0.03)
0.24
Provision for taxes on income (Note 5)
1,213
755
2,341
954
2,632
644
1,062
459
908
1,618
(669)
1,364
Provision for taxes on income percent to sales
0.05
0.03
0.1
0.04
0.12
0.03
0.05
0.02
0.04
0.06
(0.03)
0.06
Net earnings from continuing operations
-
-
-
-
-
2,694
4,686
3,255
4,309
-
-
-
Net earnings from continuing operations percent of sales
0.22
0.22
0.21
0.23
0.5
0.12
0.21
0.15
0.2
-
-
-
Net earnings from discontinued operations, net of tax (Note 13)
-
-
-
-
-
0
0
0
21,719
-
-
-
NET EARNINGS
-
-
-
-
-
-
-
-
-
-
-
-
Net Earnings percent to sales
-
-
-
-
-
-
-
-
-
-
-
-
Add: Net loss attributable to noncontrolling interest, net of tax
-
-
-
-
-
-
-
-
-
-
-
-
Net loss attributable to noncontrolling interest percent to sales
-
-
-
-
-
-
-
-
-
-
-
-
Net earnings
$ 5,534
$ 5,235
$ 5,152
$ 5,537
$ 10,999
$ 2,694
$ 4,686
$ 3,255
$ 26,028
$ 5,144
$ (68)
$ 4,458
Net earnings percent to sales
-
-
-
-
-
-
-
-
-
0.2
0
0.19
NET EARNINGS PER SHARE
                                                    
Continuing operations - basic (in dollars per share)
-
-
-
-
-
$ 1.12
$ 1.95
$ 1.35
$ 1.71
-
-
-
Discontinued operations - basic (in dollars per share)
-
-
-
-
-
0
0
0
8.61
-
-
-
Total net earnings per share - basic (in dollars per share)
2.3
2.17
2.14
2.3
4.57
1.12
1.95
1.35
10.32
1.98
(0.03)
1.7
Continuing operations - diluted (in dollars per share)
-
-
-
-
-
1.11
1.93
1.34
1.69
-
-
-
Discontinued operations - diluted (in dollars per share)
-
-
-
-
-
0
0
0
8.52
-
-
-
Total net earnings per share - diluted (in dollars per share)
2.27
2.14
2.12
2.29
4.54
1.11
1.93
1.34
10.21
1.96
(0.03)
1.68
CASH DIVIDENDS PER SHARE
-
-
-
-
-
-
-
-
-
-
-
-
Avg. shares outstanding
                                                    
Basic (shares)
2,407.4
2,408.7
2,408.3
2,406.3
2,407.2
2,407.2
2,406.8
2,408.2
2,522.9
2,598.4
2,605.5
2,627.9
Diluted (shares)
2,440.1
2,445.2
2,428.6
2,419.1
2,423.8
2,427.9
2,422
2,430.1
2,549.7
2,625.7
2,605.5
2,661.3
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
-
-
-
-
-
-
-
-
-
-
-
-